Showing 1–6 of 6 results
-
Research |
-
Research | | Open
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
- M B Miranda
- , M Lauseker
- , M-P Kraus
- , U Proetel
- , B Hanfstein
- , A Fabarius
- , G M Baerlocher
- , D Heim
- , D K Hossfeld
- , H-J Kolb
- , S W Krause
- , C Nerl
- , T H Brümmendorf
- , W Verbeek
- , A A Fauser
- , O Prümmer
- , K Neben
- , U Hess
- , R Mahlberg
- , C Plöger
- , M Flasshove
- , B Rendenbach
- , W-K Hofmann
- , M C Müller
- , M Pfirrmann
- , A Hochhaus
- , J Hasford
- , R Hehlmann
- & S Saußele
-
-
-
-
Research | | Open
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
- R Hehlmann
- , M Lauseker
- , S Saußele
- , M Pfirrmann
- , S Krause
- , H J Kolb
- , A Neubauer
- , D K Hossfeld
- , C Nerl
- , A Gratwohl
- , G M Baerlocher
- , D Heim
- , T H Brümmendorf
- , A Fabarius
- , C Haferlach
- , B Schlegelberger
- , M C Müller
- , S Jeromin
- , U Proetel
- , K Kohlbrenner
- , A Voskanyan
- , S Rinaldetti
- , W Seifarth
- , B Spieß
- , L Balleisen
- , M C Goebeler
- , M Hänel
- , A Ho
- , J Dengler
- , C Falge
- , L Kanz
- , S Kremers
- , A Burchert
- , M Kneba
- , F Stegelmann
- , C A Köhne
- , H W Lindemann
- , C F Waller
- , M Pfreundschuh
- , K Spiekermann
- , W E Berdel
- , L Müller
- , M Edinger
- , J Mayer
- , D W Beelen
- , M Bentz
- , H Link
- , B Hertenstein
- , R Fuchs
- , M Wernli
- , F Schlegel
- , R Schlag
- , M de Wit
- , L Trümper
- , H Hebart
- , M Hahn
- , J Thomalla
- , C Scheid
- , P Schafhausen
- , W Verbeek
- , M J Eckart
- , W Gassmann
- , A Pezzutto
- , M Schenk
- , P Brossart
- , T Geer
- , S Bildat
- , E Schäfer
- , A Hochhaus
- & J Hasford
